Jordi Giralt, MD, PhD, pathology, radiology, oncology, University Hospital Vall d'Hebron, discusses a study that examined mucoadhesive clonidine (Clonidine Lauriad) in the prevention of severe radiomucositis in patients with head and neck cancer.
Jordi Giralt, MD, PhD
Advertisement
Articles by Jordi Giralt, MD, PhD
Advertisement
Latest Updated Articles
Dr. Giralt on Mucoadhesive Clonidine in Head and Neck CancerPublished: August 26th 2015 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
The OncFive: Top Oncology Articles for the Week of 1/25
5